748 related articles for article (PubMed ID: 17177977)
41. Enhanced contact hypersensitivity and antiviral immune responses in vivo by keratinocyte-targeted overexpression of IL-15.
Loser K; Mehling A; Apelt J; Ständer S; Andres PG; Reinecker HC; Eing BR; Skryabin BV; Varga G; Schwarz T; Beissert S
Eur J Immunol; 2004 Jul; 34(7):2022-31. PubMed ID: 15214050
[TBL] [Abstract][Full Text] [Related]
42. Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells.
Dai R; Grammer SF; Streilein JW
J Immunol; 1993 Jan; 150(1):59-66. PubMed ID: 8417131
[TBL] [Abstract][Full Text] [Related]
43. Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation.
Koch F; Heufler C; Kämpgen E; Schneeweiss D; Böck G; Schuler G
J Exp Med; 1990 Jan; 171(1):159-71. PubMed ID: 2404080
[TBL] [Abstract][Full Text] [Related]
44. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells.
Heufler C; Koch F; Schuler G
J Exp Med; 1988 Feb; 167(2):700-5. PubMed ID: 3279156
[TBL] [Abstract][Full Text] [Related]
45. Stat3 activation in epidermal keratinocytes induces Langerhans cell activation to form an essential circuit for psoriasis via IL-23 production.
Nakajima K; Kataoka S; Sato K; Takaishi M; Yamamoto M; Nakajima H; Sano S
J Dermatol Sci; 2019 Feb; 93(2):82-91. PubMed ID: 30514663
[TBL] [Abstract][Full Text] [Related]
46. Langerhans cells that have matured in vivo in the absence of T cells are fully capable of inducing a helper CD4 as well as a cytotoxic CD8 response.
De Creus A; Van Beneden K; Taghon T; Stolz F; Debacker V; Plum J; Leclercq G
J Immunol; 2000 Jul; 165(2):645-53. PubMed ID: 10878336
[TBL] [Abstract][Full Text] [Related]
47. CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells.
Polak ME; Newell L; Taraban VY; Pickard C; Healy E; Friedmann PS; Al-Shamkhani A; Ardern-Jones MR
J Invest Dermatol; 2012 Jun; 132(6):1636-44. PubMed ID: 22377764
[TBL] [Abstract][Full Text] [Related]
48. Langerhans cells favor skin flora tolerance through limited presentation of bacterial antigens and induction of regulatory T cells.
van der Aar AM; Picavet DI; Muller FJ; de Boer L; van Capel TM; Zaat SA; Bos JD; Janssen H; George TC; Kapsenberg ML; van Ham SM; Teunissen MB; de Jong EC
J Invest Dermatol; 2013 May; 133(5):1240-9. PubMed ID: 23389393
[TBL] [Abstract][Full Text] [Related]
49. In vitro treatment of human transforming growth factor-beta1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction.
Aiba S; Manome H; Yoshino Y; Tagami H
Immunology; 2000 Sep; 101(1):68-75. PubMed ID: 11012755
[TBL] [Abstract][Full Text] [Related]
50. Examination of tetrachlorosalicylanilide (TCSA) photoallergy using in vitro photohapten-modified Langerhans cell-enriched epidermal cells.
Gerberick GF; Ryan CA; Von Bargen EC; Stuard SB; Ridder GM
J Invest Dermatol; 1991 Aug; 97(2):210-8. PubMed ID: 1649226
[TBL] [Abstract][Full Text] [Related]
51. Engagement of CD47 inhibits the contact hypersensitivity response via the suppression of motility and B7 expression by Langerhans cells.
Yu X; Fukunaga A; Nagai H; Oniki S; Honma N; Ichihashi M; Matozaki T; Nishigori C; Horikawa T
J Invest Dermatol; 2006 Apr; 126(4):797-807. PubMed ID: 16456531
[TBL] [Abstract][Full Text] [Related]
52. Granulocyte/macrophage colony-stimulating factor inhibits IL-12 production of mouse Langerhans cells.
Tada Y; Asahina A; Nakamura K; Tomura M; Fujiwara H; Tamaki K
J Immunol; 2000 May; 164(10):5113-9. PubMed ID: 10799868
[TBL] [Abstract][Full Text] [Related]
53. Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells.
Tokura Y; Kobayashi M; Ito T; Takahashi H; Matsubara A; Takigawa M
Cell Immunol; 2003 Jul; 224(1):47-54. PubMed ID: 14572800
[TBL] [Abstract][Full Text] [Related]
54. Alpha 6 integrins are required for Langerhans cell migration from the epidermis.
Price AA; Cumberbatch M; Kimber I; Ager A
J Exp Med; 1997 Nov; 186(10):1725-35. PubMed ID: 9362532
[TBL] [Abstract][Full Text] [Related]
55. Multiphoton high-resolution 3D imaging of Langerhans cells and keratinocytes in the mouse skin model adopted for epidermal powdered immunization.
Mulholland WJ; Arbuthnott EA; Bellhouse BJ; Cornhill JF; Austyn JM; Kendall MA; Cui Z; Tirlapur UK
J Invest Dermatol; 2006 Jul; 126(7):1541-8. PubMed ID: 16645596
[TBL] [Abstract][Full Text] [Related]
56. [Identification of Langerhans cells in dermatology].
Lipozencić J; Ljubojević S
Arh Hig Rada Toksikol; 2004 Jun; 55(2-3):167-74. PubMed ID: 15285465
[TBL] [Abstract][Full Text] [Related]
57. Langerhans cells from oral epithelium are more effective in stimulating allogeneic t-cells in vitro than Langerhans cells from skin epithelium.
Hasséus B; Jontell M; Bergenholtz G; Eklund C; Dahlgren UI
J Dent Res; 1999 Mar; 78(3):751-8. PubMed ID: 10096450
[TBL] [Abstract][Full Text] [Related]
58. Alterations of immune functions in barrier disrupted skin by UVB irradiation.
Ito T; Seo N; Yagita H; Tsujimura K; Takigawa M; Tokura Y
J Dermatol Sci; 2003 Dec; 33(3):151-9. PubMed ID: 14643520
[TBL] [Abstract][Full Text] [Related]
59. Changing views of the role of Langerhans cells.
Romani N; Brunner PM; Stingl G
J Invest Dermatol; 2012 Mar; 132(3 Pt 2):872-81. PubMed ID: 22217741
[TBL] [Abstract][Full Text] [Related]
60. Functional dichotomy between Langerhans cells that present antigen to naive and to memory/effector T lymphocytes.
Streilein JW; Grammer SF; Yoshikawa T; Demidem A; Vermeer M
Immunol Rev; 1990 Oct; 117():159-83. PubMed ID: 2258190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
